Scott M. Blackman, M.D., Ph.D.
David M. Rubenstein Child Health Building
Endocrine and Diabetes clinic – Wednesdays (2 per month)
Vanderbilt University School of Medicine – Molecular Physiology and BiophysicsMedical School:
Vanderbilt University School of MedicineResidency:
Johns Hopkins University School of Medicine – PediatricsFellowship:
Johns Hopkins University School of Medicine – Pediatric Endocrinology
- Pituitary and other endocrine disorders
- Cystic fibrosis related to diabetes and other endocrine complications of CF
Dr. Scott M. Blackman is an Assistant Professor of Pediatrics at the Johns Hopkins University School of Medicine. He completed his undergraduate studies at Princeton University and received his M.D. and Ph.D. degrees from the Vanderbilt University School of Medicine. He completed his internship and residency in Pediatrics and fellowship in Pediatric Endocrinology at Johns Hopkins and has been a faculty member at Johns Hopkins since 2007.
Dr. Blackman cares for patients with all types of endocrine disorders, including diabetes, disorders of growth, puberty, and the thyroid and pituitary glands. Dr. Blackman also started and runs a multidisciplinary clinic for pediatric patients with endocrine complications of cystic fibrosis.
Dr. Blackman's research interests are in how gene variants cause diabetes and other metabolic disorders. People with cystic fibrosis (CF) are at very high risk to develop diabetes, and his projects aim to determine how a person's genetic background along with the mutations in CFTR (the gene that causes CF) combine to cause diabetes and other complications of CF. As an investigator for the T1D Exchange, a nationwide study of type 1 diabetes, he led a study relating insulin pump use to diabetes outcomes in infants and toddlers with type 1 diabetes.
Dr. Blackman is a recipient of the 2014 Gilead Research Scholars Award and has received awards from the Pediatric Endocrine Society and Cystic Fibrosis Foundation. He serves on study sections for the NIH (NIDDK) and the Cystic Fibrosis Foundation, the Program Planning Committee for the North American CF Conference, and is an associate editor of the Journal of Cystic Fibrosis. He is a member of the Society for Pediatric Research and is a U.S. News Top Doctor.
- Molecular genetics of diabetes and cystic fibrosis
- The molecular mechanism of CF-related diabetes
- Mechanisms regulating weight gain and nutritional status in CF
- The amount of CFTR function necessary to reduce the risk of CF complications
- Use of insulin pumps in infants and toddlers with diabetes
Dr. Blackman's CV